Salesforce (NYSE:CRM – Get Free Report)‘s stock had its “overweight” rating reiterated by research analysts at Cantor Fitzgerald in a note issued to investors on Thursday, Benzinga reports. They presently have a $300.00 price objective on the CRM provider’s stock. Cantor Fitzgerald’s price target suggests a potential upside of 19.70% from the stock’s current price. […]

Amgen (NASDAQ:AMGN – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They currently have a $400.00 target price on the medical research company’s stock. Cantor Fitzgerald’s target price indicates a potential downside of 8.51% from the stock’s previous close. Several other […]